The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
The Kallikrein-Kinin System: Current and Future Pharmacological Targets
Open accessAbstract
The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). This complex system includes the precursors of kinins known as kininogens and mainly tissue and plasma kallikreins. The pharmacologically active kinins, which are often considered as either proinflammatory or cardioprotective, are implicated in many physiological and pathological processes. The interest of the various components of this multi-protein system is explained in part by the multiplicity of its pharmacological activities, mediated not only by kinins and their receptors, but also by their precursors and their activators and the metallopeptidases and the antiproteases that limit their activities. The regulation of this system by serpins and the wide distribution of the different constituents add to the complexity of this system, as well as its multiple relationships with other important metabolic pathways such as the renin-angiotensin, coagulation, or complement pathways. The purpose of this review is to summarize the main properties of this kallikrein-kinin system and to address the multiple pharmacological interventions that modulate the functions of this system, restraining its proinflammatory effects or potentiating its cardiovascular properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During ACE inhibition, bradykinin is primarily inactivated by aminopeptidase P (APP).”
From Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema (2010) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
MEROPS: the peptidase database
Rawlings, N. D., & Barrett, A. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.325 · Cited by 2,284
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J., Arveiler, D., Luc, G., Bard, J., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,908
Køber, L., Torp-Pedersen, C. T., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,768
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Research works printed but not linked: 5
- 1 Abelous J, Bardier E. Les substances hypotensives de l’urine humaine normale. CR Soc Biol. 1909;66:511-512. (in French)
- 209 Rosenkrans B, Russmann S, Reichen J, Brunner-Ferber F, Bork K, Knolle J. Clinical proof-of-concept fort he bradykinin B2 antagonist; icatibant in liver cirrhosis and hereditary angioedema. Peptide Receptors Montreal 2004 Symposium. Montreal, Canada, 2004.
- 222 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153. · DOI · Paper page
- 241 Dumoulin MJ, Lamontagne D, Burnett J, Heublein D, Yamaguchi N, Adam A. Respective role of endogenous kinins and natriuretic peptides in the cardioprotective effect of omapatrilat following total heart ischemia (abstract). Eur Heart J. 2001;22:50.
- 250 Duan Q, Nikpoor B, Molinaro G, Meijer I, Rochefort D, Saint-Onge J, et al. Variants in XPNPEP2 increase susceptibility to ACE-inhibitor associated adverse reactions. Am J Hum Genet. In press 2005.
Cited by
Sorted by citations
Items 201–300 of 469
Kim, S. M., Park, S., & Choue, R. (2010) · Food Science and Biotechnology · doi:10.1007/s10068-010-0201-0 · Cited by 20
Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
Cao, B., Yu, Q., Zhao, W., Tang, Z., Cong, B., Du, J., Lu, J., Zhu, X., & Ni, X. (2016) · Scientific Reports · doi:10.1038/srep20024 · Cited by 20
Ferreira, A. P. O., Rodrigues, F. S., Della-Pace, I. D., Mota, B. C., Oliveira, S. M., Gewehr, C. D. C. V., Bobinski, F., de Oliveira, C. V., Brum, J. S., Oliveira, M. S., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3336-x · Cited by 19
Nociceptors in Cardiovascular Functions: Complex Interplay as a Result of Cyclooxygenase Inhibition
Premkumar, L. S., & Raisinghani, M. (2006) · Molecular Pain · doi:10.1186/1744-8069-2-26 · Cited by 19
Kinin-kallikrein system: New perspectives in heart failure
Mohammadi, K., Shafie, D., Ghomashi, N., Abdolizadeh, A., & Sadeghpour, M. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10393-y · Cited by 18
Analgesic Effects of 3-Substituted Derivatives of 1,4-Benzodiazepines and their Possible Mechanisms
Pavlovsky, V. І., Tsymbalyuk, О. V., Martynyuk, V. S., Кабанова, Т. А., Semenishyna, E. A., Халимова, Е. И., & Andronati, S. A. (2013) · Neurophysiology · doi:10.1007/s11062-013-9389-y · Cited by 18
Atherton, M. J., Braceland, M., Harvie, J., Burchmore, R., Eadie, S., Eckersall, P. D., & Morris, J. S. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.12.011 · Cited by 18
Kanoo, S., Alex, A. B., Tiwari, A. K., & Deshpande, S. B. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01953.x · Cited by 18
Catalán, M., Smolic, C., Contreras‐Ferrat, A. E., Ayala, P., Olmedo, I., Copaja, M., Boza, P., Vivar, R., Avalos, Y., Lavandero, S., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.013 · Cited by 18
Misumi, Y., & Ikehara, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00745-6 · Cited by 18
Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches
Zarfeshani, A., Carroll, K. R., Volpe, B. T., & Diamond, B. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00992-1 · Cited by 17
Fialho, M. F. P., Brum, E. D. S., Becker, G., Brusco, I., & Oliveira, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041136 · Cited by 17
de Araújo, C. N., Bussacos, A., Sousa, A. O., Hecht, M. M., & Teixeira, A. R. L. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.001 · Cited by 17
Lee, E., Kim, S., Choi, M., Yang, H., Park, S., Oh, H., Moon, K., Han, J., Kim, Y., Yoon, S., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4052 · Cited by 17
An overview of kinin mediated events in cancer progression and therapeutic applications
Deepak, K., Roy, P., Kola, P., Mukherjee, B., & Mandal, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188807 · Cited by 17
Ohyama, K., Shindo, J., Takahashi, T., Takeuchi, H., & Hori, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-17366-x · Cited by 16
Johnson, N. V., Ahn, S. H., Deshmukh, H. S., Levin, M. K., Nelson, C. L., Scott, W. K., Allen, A. S., Fowler, V. G., & Cowell, L. G. (2012) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.002501 · Cited by 16
Corbier, A., Berre, N. L., Rampe, D., Meng, H., Lorenz, M., Vicat, P., Potdevin, S., & Doubovetzky, M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr072 · Cited by 16
Kempe, S., Fois, G., Brunner, C., Hoffmann, T. K., Hahn, J., & Greve, J. (2019) · Microcirculation · doi:10.1111/micc.12592 · Cited by 16
Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure
Maurer, J., Grouzmann, E., & Eugster, P. J. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123904 · Cited by 15
Surface- and tip-enhanced Raman scattering of bradykinin onto the colloidal suspended Ag surface
Święch, D., Ozaki, Y., Kim, Y. C., & Proniewicz, L. M. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp02319j · Cited by 15
Inhibitory role of kinins on microglial nitric oxide and tumor necrosis factor-α production
Ben-Shmuel, S., Gera, L., Danon, A., Ron, A., & Fleisher‐Berkovich, S. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.026 · Cited by 15
‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension
Swietlik, E. M., Prapa, M., Martin, J. M., Pandya, D., Auckland, K., Morrell, N. W., & Gräf, S. (2020) · Genes · doi:10.3390/genes11121408 · Cited by 15
Biroš, E., Norman, P. E., Walker, P. J., Nataatmadja, M. I., West, M., & Golledge, J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.017 · Cited by 15
Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury
Estrela, G. R., Wasinski, F., Bacurau, R. F. P., Malheiros, D. M. A. C., Câmara, N. O. S., & Araújo, R. C. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.06.025 · Cited by 15
Zhao, X., Southwick, K., Cardasis, H. L., Du, Y., Lassman, M. E., Xie, D., El-Sherbeini, M., Geissler, W. M., Pryor, K. D., Verras, A., et al. (2010) · PROTEOMICS · doi:10.1002/pmic.201000145 · Cited by 15
In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases
Jean, M., Gera, L., Charest‐Morin, X., Marceau, F., & Bachelard, H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00306 · Cited by 15
Self-citationClinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital
Pall, A. H., Lomholt, A. F., von Buchwald, C., Bygum, A., & Rasmussen, E. R. (2020) · Journal of Asthma and Allergy · doi:10.2147/jaa.s245161 · Cited by 15
Kinin B1 and B2 Receptors Contribute to Cisplatin-Induced Painful Peripheral Neuropathy in Male Mice
Becker, G., Fialho, M. F. P., Brusco, I., & Oliveira, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030852 · Cited by 14
Influence of applied potential on bradykinin adsorption onto Ag, Au, and Cu electrodes
Proniewicz, L. M., Święch, D., Ignatjev, I., Niaura, G., Sobolewski, D., Prahl, A., & Proniewicz, L. M. (2013) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4246 · Cited by 14
The role of kinins in the proliferation of fibroblast primed with TNF in scratch wound assay
França, A. J. V. B. D. V., Faveri, R. D., Nunes, R., Steimbach, V. M. B., Santin, J. R., & Quintão, N. L. M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.09.036 · Cited by 14
Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions
Gregnani, M. F., Húngaro, T. G. R., Martins-Silva, L., Bäder, M., & Araújo, R. C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01162 · Cited by 14
Alterations to the maternal circulating proteome after preeclampsia
Murphy, M. S. Q., Bytautiene, E., Saade, G. R., & Smith, G. N. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.10.008 · Cited by 14
The relevance of kalikrein-kinin system via activation of B 2 receptor in LPS-induced fever in rats
Soares, D. D. M., Santos, D. R., Rummel, C. D., Ott, D., Melo, M. C. C., Roth, J., Calixto, J. Β., & de Souza, G. E. P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.019 · Cited by 14
Giovanella, J., Wollinger, L. M., Capra, L., Dresch, F., Genro, J. P., & Contini, V. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03983-5 · Cited by 14
Bradykinin Release Avoids High Molecular Weight Kininogen Endocytosis
Damasceno, I. Z., Melo, K. R. B., Nascimento, F. D., Souza, D. S. P., Araújo, M. S., Souza, S. E. G., Sampaio, M. U., Nader, H. B., Tersariol, I. L. S., & Motta, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121721 · Cited by 14
Roskiewicz, F., Andriamanana, I., Gras‐Champel, V., Andréjak, M., & Massy, Z. A. (2007) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2007.03.003 · Cited by 14
The Kinin System: Present and Future Pharmacological Targets
Sharma, J. N., & AL-Sherif, G. J. (2011) · American Journal of Biomedical Sciences · doi:10.5099/aj110200156 · Cited by 14
Contact System Activation in Patients with HAE and Normal C1 Inhibitor Function
Ghannam, A., Defendi, F., Charignon, D., Csopaki, F., Favier, B., Habib, M., Cichon, S., & Drouet, C. (2013) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2013.07.007 · Cited by 13
Bawolak, M., Touzin, K., Moreau, M. E., Désormeaux, A., Adam, A. A., & Marceau, F. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.09.004 · Cited by 13
Self-citationThe relaxant effect of the Montivipera bornmuelleri snake venom on vascular contractility.
Accary, C., Hraoui-Bloquet, S., Sadek, R. A., Alameddine, A., Fajloun, Z., Desfontis, J., & Mallem, Y. (2016) · PubMed Central · Cited by 13
Pathophysiology of Primary Hypertension
Carey, R. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00020-6 · Cited by 13
Bourdet, B., Pécher, C., Minville, V., Jaafar, A., Allard, J., Blaes, N., Girolami, J., & Tack, I. (2010) · Neuropeptides · doi:10.1016/j.npep.2009.12.005 · Cited by 13
Dumoulin, M., Adam, A. A., Burnett, J. C. J., Heublein, D. M., Yamaguchi, N., & Lamontagne, D. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-134 · Cited by 13
Self-citationSobolevskaya, E. V., Анатольевич, Ш. О., Александрович, С. М., Гуськов, А. Е., Malysheva, A. V., Atuchin∥⊥, V. V., & Nimaev, V. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109096 · Cited by 12
Ran, X., Xu, T., Ruan, H., Wang, X., & Zhang, Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107435 · Cited by 12
Zhao, H., Wang, M., Huang, X., Wu, X., Xiao, H., Jin, F., Lv, J., Cheng, J., Zhao, Y., & Zhang, C. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2032207 · Cited by 12
Brusco, I., Becker, G., Palma, T. V., Pillat, M. M., Scussel, R., Steiner, B. T., Sampaio, T. B., Ardisson-Araújo, D. M. P., de Andrade, C. M., Oliveira, M. S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-31535-6 · Cited by 12
Venom Bradykinin-Related Peptides (BRPs) and Its Multiple Biological Roles
Lameu, C., Neiva, M., & Hayashi, M. A. F. (2013) · InTech eBooks · doi:10.5772/52872 · Cited by 12
Zhang, Q., Ran, X., & Wang, D. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091780 · Cited by 12
Piccard, H., Hu, J., Fiten, P., Proost, P., Martens, E., den Steen, P. E. V., Damme, J. V., & Opdenakker, G. (2009) · Electrophoresis · doi:10.1002/elps.200800698 · Cited by 12
The kinin system in hypertensive pathophysiology
Sharma, J. N. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0137-5 · Cited by 12
Purwaningroom, D. L., Saifurrohman, M., Widodo, N., Putri, J. F., & Lukitasari, M. (2015) · International Journal for Computational Biology · doi:10.34040/ijcb.4.2.2015.61 · Cited by 12
Theilig, F., Dêbiec, H., Nafz, B., Ronco, P. M., Nüsing, R. M., Seyberth, H. W., Pavenstädt, H. J., Bouby, N., & Bachmann, S. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2006 · Cited by 12
Urodilatin reverses the detrimental influence of bradykinin in acute ischemic stroke
Dobrivojević, M., Špiranec, K., Gorup, D., Erjavec, I., Habek, N., Radmilović, M., Unfirer, S., Ćosić, A., Drenjančević, I., Gajović, S., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.007 · Cited by 12
Activation of the Bradykinin System by Angiotensin-Converting Enzyme Inhibitors
Sharma, J. N. (2010) · European Journal of Inflammation · doi:10.1177/1721727x1000800201 · Cited by 12
Święch, D., Tanabe, I., Vantasin, S., Sobolewski, D., Ozaki, Y., Prahl, A., Maćkowski, S., & Proniewicz, L. M. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03438h · Cited by 11
Bądzyńska, B., & Sadowski, J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172007 · Cited by 11
The Role of Inflammatory Mediator Bradykinin in Cardiovascular and Renal Diseases
Jn, S. (2012) · Journal of Autacoids · doi:10.4172/scientificreports.142 · Cited by 11
Fukuhara, J., Noda, K., Murata, M., Namba, S., Kinoshita, S., Dong, Z., Andõ, R., Lennikov, A., Kanda, A., & Ishida, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10512 · Cited by 11
Zhou, D., He, Y., Li, H., & Huang, W. (2021) · Oncology Letters · doi:10.3892/ol.2021.13085 · Cited by 11
Autoimmune Diabetes Is Suppressed by Treatment with Recombinant Human Tissue Kallikrein-1
Maneva-Radicheva, L., Amatya, C., Parker, C., Ellefson, J., Radichev, I., Raghavan, A., Charles, M. L., Williams, M. S., Robbins, M. S., & Savinov, A. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107213 · Cited by 11
Zhang, R., Ran, H., Peng, L., Zhang, Y., Shen, W., Sun, T., Cao, F., & Chen, Y. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12535 · Cited by 11
Guabiraba, R., Garrido, D., Bailleul, G., Trotereau, A., Pinaud, M., Lalmanach, A.-C., Chanteloup, N., & Schouler, C. (2017) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2017.04.005 · Cited by 11
Deres, L., Erős, K., Horváth, O., Bencze, N., Csekõ, C., Farkas, S., Habon, T., Tóth, K., & Halmosi, R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00624 · Cited by 11
Proteases/Antiproteases in Inflammatory Bowel Diseases
Motta, J., Martin, L., & Vergnolle, N. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0157-7_8 · Cited by 11
Zhang, Y., Huang, H., Ma, Y., Sun, Y., Wang, G., & Tang, L. (2016) · Medicine · doi:10.1097/md.0000000000005120 · Cited by 10
Bradykinin promotes Toll like receptor-4 expression in human gingival fibroblasts
Gutiérrez‐Venegas, G., Arreguín-Cano, J. A., & Bermúdez, C. H. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.07.021 · Cited by 10
Plasma Kallikrein as a Modulator of Liver Injury/Remodeling
Ahmed, I. A., Jaffa, M. A., Moussa, M., Hatem, D., El‐Achkar, G. A., Sayegh, R. A., Karam, M., Hamade, E., Habib, A., & Jaffa, A. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.715111 · Cited by 10
Kallikrein-kinin in stem cell therapy
Chao, J. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i4.448 · Cited by 10
Chromenones as potent bradykinin B1 antagonists
Bryan, M. C., Biswas, K., Peterkin, T. A. N., Rzasa, R. M., Arik, L., Lehto, S. G., Sun, H. Q., Hsieh, F.-Y., Xu, C., Fremeau, R. T., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.068 · Cited by 10
Interaction between bradykinin and natriuretic peptides via RGS protein activation in HEK-293 cells
Dobrivojević, M., Sinđić, A., Edemir, B., Kalweit, S., Forssmann, W., & Hirsch, J. R. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00033.2012 · Cited by 10
Bioactive Peptides Produced by Limited Proteolysis
de Camargo, A. C. M., Fernandes, B. L., Cruz, L., & Ferro, E. S. (2012) · Colloquium Series on Neuropeptides · doi:10.4199/c00056ed1v01y201204npe002 · Cited by 9
Levy, J., Rivard, G., Wagner, É., Beezhold, D. H., Berlin, N., Li, F., Zhang, Z., & Sussman, G. (2014) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-014-0060-y · Cited by 9
Borges, R. E., Rodrigues, E. G., Teodoro, A. C. D. S., de Moraes, M. S., Arruda, D. C., Paschoalin, T., Curcio, M. F., da Costa, P. E., do Nascimento, I. R., Calixto, L. A., et al. (2023) · Nitric Oxide · doi:10.1016/j.niox.2023.01.006 · Cited by 9
Tissue Kallikrein-Kinin Therapy in Hypertension and Organ Damage
Chao, J., Bledsoe, G., & Chao, L. (2014) · Springer eBooks · doi:10.1007/978-3-319-06683-7_3 · Cited by 9
Age-related changes in kallikreins-kinins system in rat corpus cavernosum
Wang, T., Wan, Z., Liu, J. H., Chen, M. Y., Chen, R. B., Yang, W. M., & Ye, Z. Q. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01052.x · Cited by 9
Oliveira, C. R., Paredes‐Gamero, E. J., Barbosa, C. M. V., Nascimento, F. D., Batista, E. C., Reis, F. C. G., Martins, A. H. B., Ferreira, A. T., Carmona, A. K., Pesquero, J. B., et al. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.015 · Cited by 9
Nowak, W., Errasti, A. E., Armesto, A. R., Velazque, N. L. S., & Rothlin, R. P. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.045 · Cited by 9
Silva, M. P., Bortone, F., da Silva, M. P., Araújo, T. R., Costa, M. S., & Silva, J. A. (2011) · Brazilian Journal of Physical Therapy · doi:10.1590/s1413-35552011005000005 · Cited by 9
Zhang, X., Jiang-hua, R., Lu, J., & Fan, Y. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181e5f2e2 · Cited by 9
Novel Drugs Targeting Hypertension: Renin Inhibitors and Beyond
Leibovitz, E., & Schiffrin, E. L. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318093e50d · Cited by 9
Nascimento, I. C., Glaser, T., Nery, A. A., Pillat, M. M., Pesquero, J. B., & Ulrich, H. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22726 · Cited by 9
Andrade, S. S., Silva-Lucca, R. A., Santana, L. A., Gouvea, I. E., Juliano, M. A., Carmona, A. K., Araújo, M. S., Sampaio, M. U., & Oliva, M. L. V. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.10.008 · Cited by 9
Characterization of currently marketed heparin products: Adverse event relevant bioassays
Sommers, C. D., Montpas, N., Adam, A. A., & Keire, D. A. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.04.017 · Cited by 9
Self-citationSayah, M. E., Medeiros, R., Fernandes, E. S., Campos, M. M., & Calixto, J. Β. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021097 · Cited by 9
Gene expression of kinin receptors B1 and B2 in PBMC from patients with cardiac syndrome X
Dąbek, J., Wilczok, T., Gąsior, Z., Kucia-Kuzma, S., Twardowski, R., & Kułach, A. (2007) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430701499379 · Cited by 9
Pathophysiology of Primary Hypertension
Carey, R. M. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020418 · Cited by 9
Bhoj, P. S., Nocito, C., Togre, N. S., Winfield, M., Lubinsky, C., Khan, S., Mogadala, N., Seliga, A., Unterwald, E. M., Persidsky, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810080 · Cited by 8
Bradykinin increases resensitization of purinergic receptor signaling in glioma cells
López-Valdés, H. E., Beltrán‐Parrazal, L., Brennan, K. C., & Charles, A. C. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-35 · Cited by 8
Bachelard, H., Charest‐Morin, X., & Marceau, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00273 · Cited by 8
Self-citationBen-Shmuel, S., Danon, A., & Fleisher‐Berkovich, S. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.006 · Cited by 8
Dhangadamajhi, G., & Singh, S. (2021) · Human Cell · doi:10.1007/s13577-021-00513-3 · Cited by 8
Vasoactive mediators and hypotensive transfusion reactions
Eastlund, T. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01154.x · Cited by 8
Slagter, M. H., Gooren, L. J., de Ronde, W., Soosaipillai, A. R., Scorilas, A., Giltay, E. J., Paliouras, M., & Diamandis, E. P. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068932 · Cited by 8
Characterization of the kallikrein–kinin system during the bovine ovulation process
Ilha, G. F., dos Santos, J. T., da Silveira, A. M., Gutierrez, K., Gewehr, C. D. C. V., Oliveira, S. M., Ferreira, J., Gonçalves, P. B. D., & de Oliveira, J. F. C. (2011) · Peptides · doi:10.1016/j.peptides.2011.08.028 · Cited by 7
Novel small molecule bradykinin B1 receptor antagonists. Part 1: Benzamides and semicarbazides
Schaudt, M., Locardi, E., Zischinsky, G., Stragies, R., Pfeifer, J. R., Gibson, C., Scharn, D., Richter, U., Kalkhof, H., Dinkel, K., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.119 · Cited by 7
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions
Padín, J. F., Pérez‐Ortiz, J. M., & Calvo, F. J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137209 · Cited by 7
Dose-depending effect of intracerebroventricularly administered bradykinin on nociception in rats
Bujalska‐Zadrożny, M., de Cordé, A., Cegielska-Perun, K., Gąsińska, E., & Makulska-Nowak, H. E. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71082-x · Cited by 7
Yang, M., Chiang, Y., Huang, Y., Chen, C.-C., Wang, F., Wang, C., & Kuo, Y. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000439050.08733.cf · Cited by 7
Metadata
- Authors
- Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A.
- Affiliations
- Université de Montréal (CA)
- University of Liège (BE)
- Vanderbilt University (US)
- Centre hospitalier universitaire de Québec (CA)
- Venue
- Journal of Pharmacological Sciences
- Publisher
- Japanese Pharmacological Society
- Published
- 2005
- Volume
- 99
- Issue
- 1
- Pages
- 6-38
- ISSN
- 1347-8613 (ISSN-L)
- 1347-8648
- OpenAlex
- W1967632907
- Semantic Scholar
- 11ef9af17a7b09227baf4d743022d17406b6c59a
- Cited by
- 457
- References
- 324
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 19 · 2023: 14 · 2022: 7 · 2021: 20 · 2020: 24 · 2019: 9 · 2018: 20 · 2017: 13 · 2016: 29 · 2015: 23 · 2014: 24 · 2013: 37 · 2012: 33
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079184)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- kallikrein-kinin system, bradykinin, kininogen, tissue kallikrein, plasma kallikrein, kinin receptors, metalloproteinases, antiproteases, serpins, pro-inflammatory effects, cardioprotection, renin-angiotensin system, coagulation, complement system, therapeutic target
- MeSH terms
- Angioedema, Angiotensin-Converting Enzyme Inhibitors, Animals, Bradykinin, Cardiovascular Diseases, Complement C1 Inactivator Proteins, Humans, Inflammation, Kallikreins, Aprotinin, Kidney Diseases, Peptidyl-Dipeptidase A, Kinins, Polymorphism, Genetic, Pyridines, Thiazepines, Neprilysin, Serpins, Randomized Controlled Trials as Topic, Kallikrein-Kinin System, Receptor, Bradykinin B2, Receptor, Bradykinin B1, Complement C1 Inhibitor Protein, Bradykinin B2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review